"This is to inform you that Biocon Pharma Limited, a wholly owned subsidiary of the company, has received approval for ...

The proposed Biosecure Act as well as the diversification of American and European firms away from China are expected to help ...

Itolizumab is under clinical development by Biocon and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Biocon shares had gained earlier in the day after the company and its European partner Zentiva received a decentralised ...

Biocon’s stock jumped on December 24 after the United States Food and Drug Administration (USFDA) and the European Union ...

The rise in Biocon share price came after it announced that the company and its European partner, Zentiva, have received a ...

Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY and a 36.31% jump in the Nifty Pharma ...

Bangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...

Biocon and Zentiva gain EU approval for generic Liraglutide, marking milestone in expanding complex generic medication ...

The 19-km Yellow Line (RV Road-Bommasandra) was initially scheduled for completion by the end of 2021 but faced delays due to multiple factors.